Biodesix (BDSX) Invested Capital (2019 - 2026)

Biodesix has reported Invested Capital for 8 years, with the latest figure at $9.1 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 17.43% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (down 17.43% YoY), and the FY2025 full-year result was -$2.5 million, down 111.81% from the prior year.
• Invested Capital for Q1 2026 stood at $9.1 million, up from -$2.5 million in the prior quarter.
• The five-year high for Invested Capital was $42.1 million in Q2 2024, with the low at -$2.5 million in Q4 2025.
• Historically, Invested Capital has averaged $15.8 million across 5 years, with a median of $15.8 million in 2022.
• Annual changes were most pronounced in 2024 — Invested Capital surged 456.26% — and 2025, when it tumbled 111.81%.
• Biodesix's Invested Capital stood at $30.9 million in 2022, then decreased by 14.57% to $26.4 million in 2023, then declined by 21.03% to $20.9 million in 2024, then tumbled by 111.81% to -$2.5 million in 2025, then soared by 470.47% to $9.1 million in 2026.
• The last three Invested Capital figures came in at $9.1 million (Q1 2026), -$2.5 million (Q4 2025), and -$1.7 million (Q3 2025), per Business Quant data.